CLASS III Device recall · Reported 11 Mar 2020 · FDA Enforcement Report

FilmArray NGDS Warrior Panel recalled by Biofire Defense

Biofire Defense is recalling FilmArray NGDS Warrior Panel, distributed in Colorado, Georgia, Maryland, Ohio, Texas, Utah. The recall was initiated on 20 Aug 2019 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot No./Expiration Date 457117D/2018-10-17 416118D/2019-03-15 439218D/2019-06-12 439318D/2019-07-18 454218D/2019-08-21 454318D/2019-08-22 455518D/2019-08-23 458118D/2019-09-18 458218D/2019-09-19 458018D/2019-09-20 464018D/2019-10-02 425719D/2020-05-30 462819D/2020-06-10
Quantity recalled92 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1448-2020
FDA event ID
84887
Recalling firm
Biofire Defense, Salt Lake City, UT
Classification
Class III
Status
Terminated
Recall initiated
20 Aug 2019
FDA classified
5 Mar 2020
Reported
11 Mar 2020
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

20 Aug 2019Recall initiated by company
5 Mar 2020Classified by FDA+198 days
11 Mar 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The firm has identified that an incorrect instruction for use (IFU) revision was included in the qualitative, multiplexed, nucleic acid-based in vitro diagnostic test kit.

Product as listed by the FDA

FilmArray NGDS Warrior Panel, Ref: NGDS-ASY-0007, UDI: (01)00851458005136, IVD, Rx Only

Where it was distributed

US: UT, MD, GA, CO, OH, TX, OUS: None

ColoradoGeorgiaMarylandOhioTexasUtah

Questions about this recall

Is FilmArray NGDS Warrior Panel recalled?

Yes. Biofire Defense recalled FilmArray NGDS Warrior Panel on 20 Aug 2019. The recall is Class III and its status is Terminated. Recall number Z-1448-2020.

Why was it recalled?

The firm has identified that an incorrect instruction for use (IFU) revision was included in the qualitative, multiplexed, nucleic acid-based in vitro diagnostic test kit.

Which lots are affected?

Lot No./Expiration Date 457117D/2018-10-17 416118D/2019-03-15 439218D/2019-06-12 439318D/2019-07-18 454218D/2019-08-21 454318D/2019-08-22 455518D/2019-08-23 458118D/2019-09-18 458218D/2019-09-19 458018D/2019-09-20 464018D/2019-10-02 425719D/2020-05-30 462819D/2020-06-10

Where was it sold?

US: UT, MD, GA, CO, OH, TX, OUS: None

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Biofire Defense

All 4

Other Other Medical Devices recalls

All 13,778